Xalkori is prescribed to treat people with non-small cell lung cancer (NSCLC) that is caused by known genetic defects, where the cancer has spread to other parts of the body.
| Xalkori Brand |
250mg 60 Capsules |
$3,086.00 | ||
| Xalkori Brand |
200mg 60 Capsules |
$2,972.00 |
Xalkori (generic name: crizotinib) is used to treat people with metastasized non-small cell lung cancer (NSCLC) that is caused by a genetic defect. It acts as an anti-cancer inhibitor medication for the genes anaplastic lymphoma kinase (ALK) and ROS1 (c-ros oncogene 1).
Metastatic NSCLC isn’t curable. Treatment is aimed at reducing symptom severity and prolonging life expectancy.
Do not drink grapefruit juice, eat grapefruit or take supplements containing grapefruit extract during treatment with Xalkori.
Xalkori has been prescribed because your healthcare provider has judged that the benefits are greater than the risk of side effects. Many people using this medication do not have serious side effects. It may have some serious side effects, including:
Tell your healthcare provider right away if you get any of the following signs:
Tell your healthcare provider right away if you get any of the following signs:
Tell your healthcare provider right away if you get any of the following signs:
Mild vision problems are common with Xalkori, usually happening within one week of the start of treatment. Severe vision problems may cause partial or complete loss of vision in one or both eyes. Tell your healthcare provider immediately if you have any new vision problems or any changes such as:
The most common side effects of Xalkori include:
These symptoms should reduce within a few days. If they persist or get worse, report this to your healthcare provider or pharmacist.
If non-small cell lung cancer (NSCLC) is suspected based on symptoms, a doctor may recommend imaging tests (CT, PET or MRI scans) to identify any abnormalities in the chest. A sample of the mucus or a lung biopsy can be conducted if signs confirm the likelihood of NSCLC. Genetic tests may be carried out to detect mutations that point toward the correct treatment by Xalkori in the case of ALK and ROS1 mutations.
Non-small cell lung cancer is the most common kind of lung cancer in the US. When it has spread to other parts of the body, it is known as metastatic NSCLC.
There are four stages of NSCLC, with stage four being the most severe. While NSCLC can spread to lymph nodes as early as stage 2A, by stage four the cancer cells may have spread throughout the chest and other parts of the body (metastasized).
Non-small cell lung cancer is not curable. Treatment by Xalkori aims at reducing symptom severity and prolonging life expectancy in people who have specific genetic mutations.
Send Your Prescription
No Hidden Fees
Typically Under 7 days
Are you wondering which drugs are most popular on the IsraelPharm website? Maybe you or someone you know is looking for an alternative source for your prescriptions meds? then read on if you’re curious about
In an important step, the Federal Drug Authority has pushed through an approval to get an additional dose of COVID-19 vaccines administered to the estimated 2.7 percent of adults in the United States who are
Xifaxan/Lormyx/Hepazec (generic name rifaximin) is an antibiotic that is prescribed to treat a number of conditions that cause diarrhea. Most often, it is prescribed for cases of what is commonly known as “traveler’s diarrhea,” which
Each year in April, International Foundation for Gastrointestinal Disorders (IFFGD) promotes IBS Awareness Month. Irritable bowel syndrome (IBS) is one of the most common gastrointestinal disorders, affecting up to ten percent of people worldwide. IBS
Look around you. Most TV commentators and other sources of information are looking at the “big picture” and so when they report on levels of immunization now achieving a “healthy” level of 50% of the
